1. Hong Kong Stocks

  2. •

    Consumer services

  3. •

    Other consumer services
Sino-Life Group Limited

Sino-Life Group Limited

HHKEX:8296
0.20
HKD
+0.04
(+24.20%)
64.27MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.85
0.94
0.83
0.77
0.82
0.84
0.9
0.92
0.98
1.05
0.91
0.81
0.68
- -
Basic EPS, GAAP
-0.22
-0.15
-0.13
-0.42
-0.26
-0.11
-0.05
-0.04
-0.13
-0.01
-0.09
-0.09
-0.07
- -
Free Cash Flow per Basic Share
-0.53
-0.18
0.05
-0.1
- -
0.05
0.07
0.19
-0.06
0.1
-0.04
-0.1
-0.12
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
2.48
2.33
2.19
1.8
1.54
1.42
1.7
1.61
1.54
1.52
1.4
1.31
1.27
1.3
Tangible Book Value per Share
2.48
2.33
2.19
1.7
1.46
1.38
1.7
1.61
1.52
1.51
1.39
1.31
1.22
1.3
Basic Weighted Avg Shares
74
74
74
74
74
74
74
74
74
74
80
92
95
83
Sales/Revenue/Turnover
63
70
62
57
61
63
67
68
73
78
73
75
64
- -
Operating Margin (%)
-24.05
-16.83
-15.65
-41.84
-8.91
-8.75
-6.99
3.99
-4.92
10.97
-8.46
-13.71
-15.75
- -
Depreciation Expense
6
5
5
5
6
3
7
10
8
8
8
7
7
- -
Net Income, GAAP
-16
-11
-9
-32
-19
-8
-4
-3
-10
-1
-7
-9
-7
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
231.3
- -
92.06
- -
- -
- -
- -
Profit Margin (%)
-25.63
-16
-15.25
-54.97
-31.85
-13.33
-5.71
-4.35
-13.55
-1.09
-9.88
-11.67
-10.2
- -
Working Capital
129
133
112
90
73
68
80
76
63
93
67
63
55
79
LT Debt
8
7
7
10
9
8
38
33
28
22
16
10
3
27
Total Equity
187
175
164
133
112
103
118
112
106
131
109
104
98
106
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
-3.3
- -
0.51
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
-4.7
- -
-1.46
- -
- -
- -
- -
Return on Common Equity (%)
-8.28
-6.24
-5.61
-21.29
-15.57
-7.6
-3.29
-2.42
-8.44
-0.74
-6.05
-7.04
-5.38
- -

Capital Structure

CNY

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
ST Debt
- -
21
7
LT Borrowings
- -
2
15
LT Finance Leases
- -
14
11
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
82
89
95
Market Capitalization
83
68
60

Working Capital

CNY

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
Total Current Assets
- -
213
208
Cash, Cash Equivalents & STI
- -
174
164
Accounts Receivable, Net
- -
33
1
Inventories
- -
1
1
Total Current Liabilities
- -
146
129
Payables & Accruals
- -
- -
- -
ST Debt
- -
21
7
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-4.19%
-1.68%
-5.16%
Free Cash Flow
-359.76%
-64.66%
31.29%
Net Income, GAAP
94.76%
176.82%
-24.54%
Sales/Revenue/Turnover
0.68%
-0.84%
-13.63%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
73
2024
- -
- -
75
2025
- -
- -
64

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.09
2024
- -
- -
-0.09
2025
- -
- -
-0.07

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Tien Tsai Liu
Full Time Employees
159
Sector
Consumer services
Industry
Other consumer services
Address
Ovest Hong Kong Hong Kong
IPO Date
Sep 18, 2009
Website
sinolifegroup.com
Similar Companies
Booking Holdings Inc. Common Stock (NASDAQ:BKNG)
Indian Railway Catering & Tourism Corp. Ltd. (NSE:IRCTC)
Expedia Group, Inc. (NASDAQ:EXPE)
Peloton Interactive, Inc. (NASDAQ:PTON)
Gur-Sel Turizm Tasimacilik Ve Servis Ticaret A.S. (BIST:GRSEL)
akippa Inc. (TSE:627A)
Business
Sino-Life Group Limited Sino-Life Group Limited is a Cayman Islands-incorporated investment holding company listed on the GEM board of the Hong Kong Stock Exchange since 2009 and headquartered at 18/F, Ovest, 77 Wing Lok Street, Sheung Wan, Hong Kong. The company principally engages in the provision of funeral and related services; stem cells and immunocytes business including advisory services; sales of advanced biotechnical machinery and other electronic products; and elderly care and related consultancy services, operating primarily in the People's Republic of China, Taiwan, Hong Kong, and Vietnam with 212 employees. Its core offerings encompass funeral arrangement and cremation services in managed funeral parlours and service centres, sales of burial plots and tombstones, cemetery maintenance services, biomedical technology research and testing development, and rental income from investment properties. In its two main segments, funeral services generate the bulk of revenue from cremation and arrangement services alongside burial plot sales, while the biotechnical and other businesses focus on machinery sales and stem cell advisory with minimal contribution; for the six months ended 30 June 2025, funeral services revenue reached RMB36.0 million, primarily from the PRC at RMB34.3 million, Taiwan, Hong Kong, and Vietnam. Recent major changes include a share consolidation effective 14 October 2024 following shareholder approval at an extraordinary general meeting on 9 October 2024, with adjustments to share options and convertible bonds; a lapsed proposed acquisition in January 2025 of approximately 19.46% equity interest in Guangdong Yinwei involving convertible bond issuance under specific mandate; and supplemental announcements in August 2025 regarding 2024 annual report proceeds use and 2024 interim results.